PHARMAMAR HA OPTADO POR LA RETIRADA DE LA SOLICITUD DE AUTORIZACIÓN DE COMERCIALIZACIÓN DE APLIDIN ( PLITIDEPSIN ) ... WITHDRAWAL OF APPLICATIÓN FOR THE MARKETING AUTHORISATION OF APLIDIN ( PLITIDEPSIN ) JULY 23 , 2025 .
06 enero 2023
JazzPharma . Statement of Changes In Beneficial Ownership Of Securities By COZADD BRUCE C . Chairman / CEO / Co-Founder , Jazz Pharmaceuticals PLC .
